July 5, 2017
Stada makes big board changes
STADA Arzneimittel AG has appointed Engelbert Coster Tjeenk Willink as Chief Executive Officer with immediate effect.
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
July 4, 2017
First patients get NOX-A12 combined with Keytruda in certain cancers
NOXXON Pharma, a biotechnology company whose core focus is on improving cancer treatment by targeting the tumor microenvironment, has treated first patients in its Phase 1/2 clinical trial in patients with metastatic colorectal and pancreatic cancer at the National Center for Tumor Diseases in Heidelberg, Germany.
July 3, 2017
FDA’s new orphan drug modernization plan
As the the number of orphan drug designation requests has steadily increased over the past five years, the FDA has a new plan to complete reviews of all orphan drug designation requests 90 days, that are older than 120 days (the backlog) while maintaining consistent, scientifically rigorous reviews; and after 90 days, 100% of all new orphan drug designation requests will receive a response by the agency within 90 days of receipt.
July 3, 2017
Ipsen’s third phase trial of Somatuline lead to Japan’s clearance for new indication, certain tumors
Ipsen’s partner Teijin Group healtcare’s Pharma Limited, has received approval from the Japanese Ministry of Health, Labour and Welfare for Ipsen’s subcutaneous drug Somatuline (lanreotide) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP NET).
July 3, 2017
AstraZeneca completes two commercial rights deals, payments included in Q2 2017
AstraZeneca on Monday reported closing two different agreements for certain commercial rights for its drugs, in Europe and worldwide.
July 3, 2017
Bone Therapeutics adds new board members
Bone Therapeutics, the Belgium-based bone cell therapy company focused on orthopaedics and bone diseases, has elected a new Chairman of the Board of Directors, while the previous chairman will continue as a Non-Executive Director.
July 3, 2017
Recreational marijuana becomes available in Las Vegas
DB Labs, an independent cannabis analysis laboratory in Las Vegas, is testing cannabis samples for growers and cultivators to ensure the safety of recreational users.
June 30, 2017
Bayer to cut profit view on Brazil, consumer health setbacks
Bayer said on Friday it would cut its full-year earnings forecast due to high inventories at crop protection distributors in Brazil and a weaker-than-expected consumer health business.
June 30, 2017
Roche buys diabetes app firm in digital health push
Roche has bought Vienna-based diabetes management platform mySugr for an undisclosed price, the Swiss drugmaker said on Friday, joining a growing crowd of companies expanding into app-based digital health services.
June 30, 2017
Oxford BioDynamics names new CFO
Oxford BioDynamics, focused on the epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology industry, has appointed new chief financial officer who is expected to join the company by the mid of September 2017.